Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Ropeginterferon ALFA-2B

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pint Pharma Gets ANVISA Nod For Besremi In Polycythemia Vera
    Pint Pharma Gets ANVISA Nod For Besremi In Polycythemia Vera

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250320323757/en/Pint-Pharma-Announces-ANVISAs-Approval-of-BESREMi-ropeginterferon-alfa-2b-for-the-Treatment-of-Polycythemia-Vera

    BUSINESSWIRE
    20 Mar 2025
    Share Share
    PharmaEssentia Highlights Bersremi Availability Amid Pegasys Shortage
    PharmaEssentia Highlights Bersremi Availability Amid Pegasys Shortage

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250304127897/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share
    Clinical Review of Pegylated Interferons Suggests Formulation
    Clinical Review of Pegylated Interferons Suggests Formulation

    21 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240221809028/en

    BUSINESSWIRE
    21 Feb 2024
    Share Share
    Presentations at MPN Congress Reinforce Role of ropeginterferon alfa-2b-njft
    Presentations at MPN Congress Reinforce Role of ropeginterferon alfa-2b-njft

    02 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231102403190/en

    BUSINESSWIRE
    02 Nov 2023
    Share Share
    Ropeginterferon Alfa-2b Produces Responses,Safety in Prefibrotic P Myelofibrosis
    Ropeginterferon Alfa-2b Produces Responses,Safety in Prefibrotic P Myelofibrosis

    30 Jun 2023

    // ONCLIVE

    https://www.onclive.com/view/ropeginterferon-alfa-2b-produces-responses-safety-in-prefibrotic-primary-myelofibrosis

    ONCLIVE
    30 Jun 2023
    Share Share
    PharmaEssentia Selects Pint-Pharma as Commercial Partner for BESREMi
    PharmaEssentia Selects Pint-Pharma as Commercial Partner for BESREMi

    02 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230602005191/en

    BUSINESSWIRE
    02 Jun 2023
    Share Share